

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 6.00403399 |
| 2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.65636586 |
| 3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.65636586 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 4.65636586 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.65636586 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.65636586 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.65636586 |
| 8 | positive regulation of heat generation (GO:0031652) | 4.17070220 |
| 9 | regulation of heat generation (GO:0031650) | 3.96230005 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 3.71422132 |
| 11 | negative regulation of mast cell activation (GO:0033004) | 3.68350365 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 3.66137294 |
| 13 | regulation of fever generation (GO:0031620) | 3.63912851 |
| 14 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.62829043 |
| 15 | negative regulation of axon guidance (GO:1902668) | 3.61878016 |
| 16 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.56928880 |
| 17 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.55032984 |
| 18 | synaptic vesicle maturation (GO:0016188) | 3.53612416 |
| 19 | negative chemotaxis (GO:0050919) | 3.50511306 |
| 20 | ganglion development (GO:0061548) | 3.47885594 |
| 21 | synaptic vesicle exocytosis (GO:0016079) | 3.45908409 |
| 22 | phagosome maturation (GO:0090382) | 3.44648011 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.42869855 |
| 24 | substrate-dependent cell migration (GO:0006929) | 3.41350392 |
| 25 | cell adhesion mediated by integrin (GO:0033627) | 3.38039744 |
| 26 | presynaptic membrane assembly (GO:0097105) | 3.36046539 |
| 27 | platelet dense granule organization (GO:0060155) | 3.30549922 |
| 28 | limb bud formation (GO:0060174) | 3.30037616 |
| 29 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.26050302 |
| 30 | axon extension involved in axon guidance (GO:0048846) | 3.26050302 |
| 31 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.25856866 |
| 32 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.24789894 |
| 33 | tryptophan catabolic process (GO:0006569) | 3.12329153 |
| 34 | indole-containing compound catabolic process (GO:0042436) | 3.12329153 |
| 35 | indolalkylamine catabolic process (GO:0046218) | 3.12329153 |
| 36 | proline transport (GO:0015824) | 3.11556312 |
| 37 | response to host immune response (GO:0052572) | 3.10310280 |
| 38 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.10310280 |
| 39 | layer formation in cerebral cortex (GO:0021819) | 3.10286355 |
| 40 | kynurenine metabolic process (GO:0070189) | 3.08328202 |
| 41 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.01988790 |
| 42 | negative regulation of cell killing (GO:0031342) | 3.01988790 |
| 43 | presynaptic membrane organization (GO:0097090) | 2.99853188 |
| 44 | locomotory exploration behavior (GO:0035641) | 2.99558882 |
| 45 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.98597828 |
| 46 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.98352246 |
| 47 | amine catabolic process (GO:0009310) | 2.97581712 |
| 48 | cellular biogenic amine catabolic process (GO:0042402) | 2.97581712 |
| 49 | regulation of action potential (GO:0098900) | 2.94107792 |
| 50 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.92310127 |
| 51 | clathrin coat assembly (GO:0048268) | 2.90431590 |
| 52 | negative regulation of lipid storage (GO:0010888) | 2.90354139 |
| 53 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.87690159 |
| 54 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.84546918 |
| 55 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.84471834 |
| 56 | response to pheromone (GO:0019236) | 2.83562608 |
| 57 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.83502957 |
| 58 | tryptophan metabolic process (GO:0006568) | 2.82229221 |
| 59 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.81086791 |
| 60 | transferrin transport (GO:0033572) | 2.80675997 |
| 61 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.80344955 |
| 62 | positive regulation of protein autophosphorylation (GO:0031954) | 2.79741762 |
| 63 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.79191841 |
| 64 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.77860958 |
| 65 | response to host (GO:0075136) | 2.77860958 |
| 66 | response to host defenses (GO:0052200) | 2.77860958 |
| 67 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.77115907 |
| 68 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.76894839 |
| 69 | L-amino acid import (GO:0043092) | 2.75939123 |
| 70 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.75623885 |
| 71 | positive regulation of mast cell degranulation (GO:0043306) | 2.75623885 |
| 72 | regulation of axon guidance (GO:1902667) | 2.74921895 |
| 73 | magnesium ion transport (GO:0015693) | 2.74735978 |
| 74 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.73239517 |
| 75 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.73103479 |
| 76 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.72855631 |
| 77 | regulation of synapse structural plasticity (GO:0051823) | 2.72596825 |
| 78 | microglial cell activation (GO:0001774) | 2.72581314 |
| 79 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.72048153 |
| 80 | neuron cell-cell adhesion (GO:0007158) | 2.71705737 |
| 81 | behavioral response to nicotine (GO:0035095) | 2.69902928 |
| 82 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.68208820 |
| 83 | regulation of chronic inflammatory response (GO:0002676) | 2.67971675 |
| 84 | positive regulation of mast cell activation (GO:0033005) | 2.67654756 |
| 85 | anterior/posterior axis specification, embryo (GO:0008595) | 2.67631359 |
| 86 | protein localization to synapse (GO:0035418) | 2.65791718 |
| 87 | dendrite morphogenesis (GO:0048813) | 2.65040270 |
| 88 | prostate gland growth (GO:0060736) | 2.65027643 |
| 89 | vocalization behavior (GO:0071625) | 2.63698416 |
| 90 | indolalkylamine metabolic process (GO:0006586) | 2.63044321 |
| 91 | cellular potassium ion homeostasis (GO:0030007) | 2.62743245 |
| 92 | regulation of hippo signaling (GO:0035330) | 2.61952718 |
| 93 | positive regulation of mitochondrial fission (GO:0090141) | 2.61896189 |
| 94 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.61259460 |
| 95 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.61259460 |
| 96 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.60358264 |
| 97 | cellular response to ATP (GO:0071318) | 2.60120025 |
| 98 | glutamate secretion (GO:0014047) | 2.59765446 |
| 99 | negative regulation of JAK-STAT cascade (GO:0046426) | 2.59512014 |
| 100 | negative regulation of interleukin-17 production (GO:0032700) | 2.59127478 |
| 101 | trivalent inorganic cation transport (GO:0072512) | 2.58881364 |
| 102 | ferric iron transport (GO:0015682) | 2.58881364 |
| 103 | myeloid cell activation involved in immune response (GO:0002275) | 2.58323497 |
| 104 | axonal fasciculation (GO:0007413) | 2.58117916 |
| 105 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.57525266 |
| 106 | peristalsis (GO:0030432) | 2.55645845 |
| 107 | microtubule cytoskeleton organization involved in mitosis (GO:1902850) | 2.54948791 |
| 108 | positive regulation of leukocyte degranulation (GO:0043302) | 2.54683595 |
| 109 | positive regulation of macrophage cytokine production (GO:0060907) | 2.53991974 |
| 110 | negative regulation of monooxygenase activity (GO:0032769) | 2.52603386 |
| 111 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.51435277 |
| 112 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.50845921 |
| 113 | regulation of leukocyte degranulation (GO:0043300) | 2.50509982 |
| 114 | regulation of regulated secretory pathway (GO:1903305) | 2.49832171 |
| 115 | dendritic spine morphogenesis (GO:0060997) | 2.49733607 |
| 116 | respiratory burst (GO:0045730) | 2.48744783 |
| 117 | regulation of mast cell degranulation (GO:0043304) | 2.48506678 |
| 118 | neuron recognition (GO:0008038) | 2.48439191 |
| 119 | amino acid import (GO:0043090) | 2.46440862 |
| 120 | vesicle transport along microtubule (GO:0047496) | 2.45723366 |
| 121 | response to lipoprotein particle (GO:0055094) | 2.45621544 |
| 122 | macrophage activation (GO:0042116) | 2.44629360 |
| 123 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.43921091 |
| 124 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.42828895 |
| 125 | cerebral cortex cell migration (GO:0021795) | 2.42738778 |
| 126 | nerve growth factor signaling pathway (GO:0038180) | 2.42160192 |
| 127 | glycosphingolipid biosynthetic process (GO:0006688) | 2.42127485 |
| 128 | granulocyte activation (GO:0036230) | 2.42028339 |
| 129 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.41902077 |
| 130 | positive regulation of action potential (GO:0045760) | 2.41042044 |
| 131 | postsynaptic membrane organization (GO:0001941) | 2.40970208 |
| 132 | regulation of ARF protein signal transduction (GO:0032012) | 2.40662429 |
| 133 | glutamate receptor signaling pathway (GO:0007215) | 2.40534717 |
| 134 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.40225334 |
| 135 | negative regulation of axon extension (GO:0030517) | 2.39494308 |
| 136 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.39487061 |
| 137 | exploration behavior (GO:0035640) | 2.39383853 |
| 138 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.38716336 |
| 139 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.37454769 |
| 140 | negative regulation of amino acid transport (GO:0051956) | 2.37305137 |
| 141 | spinal cord development (GO:0021510) | 2.37175183 |
| 142 | eosinophil chemotaxis (GO:0048245) | 2.37108966 |
| 143 | regulation of mononuclear cell migration (GO:0071675) | 2.36389428 |
| 144 | alanine transport (GO:0032328) | 2.36374207 |
| 145 | neurotransmitter secretion (GO:0007269) | 2.36049907 |
| 146 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.35479028 |
| 147 | tachykinin receptor signaling pathway (GO:0007217) | 2.34230093 |
| 148 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.34185736 |
| 149 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.33985733 |
| 150 | artery development (GO:0060840) | 2.33024713 |
| 151 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.32685719 |
| 152 | semaphorin-plexin signaling pathway (GO:0071526) | 2.32256569 |
| 153 | response to caffeine (GO:0031000) | 2.32237274 |
| 154 | retinal ganglion cell axon guidance (GO:0031290) | 2.32070433 |
| 155 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.30956841 |
| 156 | response to nerve growth factor (GO:1990089) | 2.30956841 |
| 157 | regulation of axon extension (GO:0030516) | 2.30916515 |
| 158 | cellular response to vitamin D (GO:0071305) | 2.30732964 |
| 159 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.30497622 |
| 160 | gamma-aminobutyric acid transport (GO:0015812) | 2.30378043 |
| 161 | response to peptidoglycan (GO:0032494) | 2.30344778 |
| 162 | neuronal action potential propagation (GO:0019227) | 2.28435056 |
| 163 | regulation of vitamin metabolic process (GO:0030656) | 2.28137933 |
| 164 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.28012410 |
| 165 | sphingosine metabolic process (GO:0006670) | 2.27993743 |
| 166 | spindle assembly involved in mitosis (GO:0090307) | 2.27842258 |
| 167 | mating behavior (GO:0007617) | 2.27723657 |
| 168 | protein localization to endosome (GO:0036010) | 2.27200501 |
| 169 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.26698347 |
| 170 | chondrocyte proliferation (GO:0035988) | 2.26568797 |
| 171 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.26356397 |
| 172 | neutrophil chemotaxis (GO:0030593) | 2.25706037 |
| 173 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.25458845 |
| 174 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.25398440 |
| 175 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.25052065 |
| 176 | neural tube formation (GO:0001841) | 2.24938790 |
| 177 | regulation of extent of cell growth (GO:0061387) | 2.24837221 |
| 178 | activation of protein kinase A activity (GO:0034199) | 2.24601927 |
| 179 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.24333794 |
| 180 | positive regulation of muscle hypertrophy (GO:0014742) | 2.23737212 |
| 181 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.23737212 |
| 182 | urinary tract smooth muscle contraction (GO:0014848) | 2.23234089 |
| 183 | behavioral response to ethanol (GO:0048149) | 2.23198745 |
| 184 | neuromuscular process controlling balance (GO:0050885) | 2.22784611 |
| 185 | sympathetic nervous system development (GO:0048485) | 2.22753480 |
| 186 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 2.22679145 |
| 187 | cerebellar Purkinje cell layer development (GO:0021680) | 2.21869919 |
| 188 | regulation of glutamate secretion (GO:0014048) | 2.21357603 |
| 189 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.21325537 |
| 190 | regulation of synaptic vesicle transport (GO:1902803) | 2.21179789 |
| 191 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.21088092 |
| 192 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.20899068 |
| 193 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.17464780 |
| 194 | regulation of collateral sprouting (GO:0048670) | 2.17318886 |
| 195 | regulation of telomere maintenance (GO:0032204) | 2.15522533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.21877127 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.46237839 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.88759553 |
| 4 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.80502294 |
| 5 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.63467938 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.41811357 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.29400931 |
| 8 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.26053595 |
| 9 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.22565871 |
| 10 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.14476103 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.12105124 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05840052 |
| 13 | FUS_26573619_Chip-Seq_HEK293_Human | 2.03004133 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.00799156 |
| 15 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.00041199 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.97343775 |
| 17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.96097272 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.95283030 |
| 19 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.88179258 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.87665139 |
| 21 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.87365962 |
| 22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.85664102 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.85664102 |
| 24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.80922194 |
| 25 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.80603096 |
| 26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.80410317 |
| 27 | EWS_26573619_Chip-Seq_HEK293_Human | 1.78928531 |
| 28 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.75785549 |
| 29 | VDR_22108803_ChIP-Seq_LS180_Human | 1.74470500 |
| 30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.73910192 |
| 31 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.73210910 |
| 32 | CJUN_26792858_Chip-Seq_BT549_Human | 1.73051821 |
| 33 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.71952255 |
| 34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.71577439 |
| 35 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.68588968 |
| 36 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.68097136 |
| 37 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.63600557 |
| 38 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.60000006 |
| 39 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.58425628 |
| 40 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.57560557 |
| 41 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.52698612 |
| 42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.51573024 |
| 43 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.50879527 |
| 44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.48848772 |
| 45 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.47454922 |
| 46 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.46769808 |
| 47 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.46381537 |
| 48 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.44224747 |
| 49 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.44174263 |
| 50 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.44174263 |
| 51 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.43772087 |
| 52 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.43474511 |
| 53 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.43193485 |
| 54 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.42520265 |
| 55 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.42054200 |
| 56 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.41950908 |
| 57 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.40787262 |
| 58 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.40270273 |
| 59 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.39304821 |
| 60 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.38488620 |
| 61 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.38204675 |
| 62 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.38144049 |
| 63 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.37303486 |
| 64 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.34880663 |
| 65 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.33160334 |
| 66 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.32682349 |
| 67 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.32533836 |
| 68 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.32301776 |
| 69 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31064742 |
| 70 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.30375833 |
| 71 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30285923 |
| 72 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.29934545 |
| 73 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.27783098 |
| 74 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.27294016 |
| 75 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.27276194 |
| 76 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.27276194 |
| 77 | RXR_22108803_ChIP-Seq_LS180_Human | 1.26822676 |
| 78 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.26028826 |
| 79 | SPI1_23127762_ChIP-Seq_K562_Human | 1.25200404 |
| 80 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.25074461 |
| 81 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24915704 |
| 82 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.24472677 |
| 83 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24162743 |
| 84 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.22817131 |
| 85 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.21375248 |
| 86 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.20873964 |
| 87 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.20649771 |
| 88 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.19714637 |
| 89 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.19493645 |
| 90 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.19366047 |
| 91 | JUN_21703547_ChIP-Seq_K562_Human | 1.19182323 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19153493 |
| 93 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.18076320 |
| 94 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.17026726 |
| 95 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16583029 |
| 96 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.16103693 |
| 97 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.15916944 |
| 98 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.15017083 |
| 99 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.14863739 |
| 100 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14863739 |
| 101 | KDM2B_26808549_Chip-Seq_REH_Human | 1.14520065 |
| 102 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.14198149 |
| 103 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13612506 |
| 104 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.13525640 |
| 105 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.13464765 |
| 106 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.13298057 |
| 107 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.13109289 |
| 108 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.12088064 |
| 109 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11507692 |
| 110 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.11226415 |
| 111 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10133420 |
| 112 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09861800 |
| 113 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.09561671 |
| 114 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08062909 |
| 115 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.07915745 |
| 116 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07909930 |
| 117 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07846800 |
| 118 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.07449786 |
| 119 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.07039381 |
| 120 | P300_19829295_ChIP-Seq_ESCs_Human | 1.06861054 |
| 121 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06324539 |
| 122 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06217163 |
| 123 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.06066374 |
| 124 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.06008498 |
| 125 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.05476150 |
| 126 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05323738 |
| 127 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.04667475 |
| 128 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.04012367 |
| 129 | AR_25329375_ChIP-Seq_VCAP_Human | 1.03718358 |
| 130 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.02996693 |
| 131 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.02771057 |
| 132 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02716346 |
| 133 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.02425684 |
| 134 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02068419 |
| 135 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01316465 |
| 136 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.01208021 |
| 137 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.00941112 |
| 138 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.99617942 |
| 139 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99556658 |
| 140 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99420651 |
| 141 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99175138 |
| 142 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.99098224 |
| 143 | * ER_23166858_ChIP-Seq_MCF-7_Human | 0.97183019 |
| 144 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.97108632 |
| 145 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.95462697 |
| 146 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95270658 |
| 147 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.93565496 |
| 148 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.90780116 |
| 149 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90612213 |
| 150 | STAT3_23295773_ChIP-Seq_U87_Human | 0.89527510 |
| 151 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.89152154 |
| 152 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.89123699 |
| 153 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.88028027 |
| 154 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.87564397 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.50595726 |
| 2 | MP0006054_spinal_hemorrhage | 3.64575796 |
| 3 | MP0000569_abnormal_digit_pigmentation | 3.43492433 |
| 4 | MP0003172_abnormal_lysosome_physiology | 3.35854987 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.34075675 |
| 6 | MP0003303_peritoneal_inflammation | 3.29300872 |
| 7 | MP0003880_abnormal_central_pattern | 3.10893936 |
| 8 | MP0004270_analgesia | 2.79659889 |
| 9 | MP0003635_abnormal_synaptic_transmissio | 2.67584305 |
| 10 | MP0006082_CNS_inflammation | 2.54050290 |
| 11 | MP0009046_muscle_twitch | 2.52116869 |
| 12 | MP0003950_abnormal_plasma_membrane | 2.49349885 |
| 13 | MP0002102_abnormal_ear_morphology | 2.45779728 |
| 14 | MP0002064_seizures | 2.41260309 |
| 15 | MP0003690_abnormal_glial_cell | 2.36667447 |
| 16 | MP0004510_myositis | 2.19838572 |
| 17 | MP0000604_amyloidosis | 2.16897650 |
| 18 | MP0004858_abnormal_nervous_system | 2.16344815 |
| 19 | MP0002063_abnormal_learning/memory/cond | 2.16229380 |
| 20 | MP0005367_renal/urinary_system_phenotyp | 2.14632131 |
| 21 | MP0000516_abnormal_urinary_system | 2.14632131 |
| 22 | MP0010386_abnormal_urinary_bladder | 2.13358774 |
| 23 | MP0009745_abnormal_behavioral_response | 2.10958254 |
| 24 | MP0003183_abnormal_peptide_metabolism | 2.08117037 |
| 25 | MP0003195_calcinosis | 2.06684372 |
| 26 | MP0003436_decreased_susceptibility_to | 2.02928174 |
| 27 | MP0002653_abnormal_ependyma_morphology | 2.01804743 |
| 28 | MP0003279_aneurysm | 1.99641181 |
| 29 | MP0000920_abnormal_myelination | 1.94111678 |
| 30 | MP0002751_abnormal_autonomic_nervous | 1.88642781 |
| 31 | MP0002837_dystrophic_cardiac_calcinosis | 1.87698417 |
| 32 | MP0002090_abnormal_vision | 1.83086469 |
| 33 | MP0002419_abnormal_innate_immunity | 1.80620077 |
| 34 | MP0002734_abnormal_mechanical_nocicepti | 1.77184457 |
| 35 | MP0003634_abnormal_glial_cell | 1.75470229 |
| 36 | MP0002572_abnormal_emotion/affect_behav | 1.73794729 |
| 37 | MP0002295_abnormal_pulmonary_circulatio | 1.73644419 |
| 38 | MP0003075_altered_response_to | 1.71260005 |
| 39 | MP0009384_cardiac_valve_regurgitation | 1.69843461 |
| 40 | MP0005257_abnormal_intraocular_pressure | 1.68562807 |
| 41 | MP0005171_absent_coat_pigmentation | 1.63383885 |
| 42 | MP0001486_abnormal_startle_reflex | 1.62407583 |
| 43 | MP0009053_abnormal_anal_canal | 1.62030792 |
| 44 | MP0003329_amyloid_beta_deposits | 1.58890751 |
| 45 | MP0002735_abnormal_chemical_nociception | 1.57367146 |
| 46 | MP0005000_abnormal_immune_tolerance | 1.53085001 |
| 47 | MP0001968_abnormal_touch/_nociception | 1.51407237 |
| 48 | MP0004811_abnormal_neuron_physiology | 1.51026010 |
| 49 | MP0001440_abnormal_grooming_behavior | 1.49712388 |
| 50 | MP0002733_abnormal_thermal_nociception | 1.44867753 |
| 51 | MP0001542_abnormal_bone_strength | 1.44378673 |
| 52 | MP0002282_abnormal_trachea_morphology | 1.44133505 |
| 53 | MP0009780_abnormal_chondrocyte_physiolo | 1.43964612 |
| 54 | MP0002332_abnormal_exercise_endurance | 1.43676768 |
| 55 | MP0001501_abnormal_sleep_pattern | 1.41946091 |
| 56 | MP0000778_abnormal_nervous_system | 1.41212363 |
| 57 | MP0001849_ear_inflammation | 1.38541699 |
| 58 | MP0003283_abnormal_digestive_organ | 1.37372224 |
| 59 | MP0001970_abnormal_pain_threshold | 1.37001310 |
| 60 | MP0005423_abnormal_somatic_nervous | 1.34937782 |
| 61 | MP0001835_abnormal_antigen_presentation | 1.33814203 |
| 62 | MP0002254_reproductive_system_inflammat | 1.31679146 |
| 63 | MP0001529_abnormal_vocalization | 1.31540826 |
| 64 | MP0002148_abnormal_hypersensitivity_rea | 1.31082063 |
| 65 | MP0001299_abnormal_eye_distance/ | 1.30107541 |
| 66 | MP0009764_decreased_sensitivity_to | 1.29168038 |
| 67 | MP0002272_abnormal_nervous_system | 1.28460261 |
| 68 | MP0005595_abnormal_vascular_smooth | 1.26803633 |
| 69 | MP0003633_abnormal_nervous_system | 1.26236084 |
| 70 | MP0009250_abnormal_appendicular_skeleto | 1.26032374 |
| 71 | MP0002938_white_spotting | 1.25670724 |
| 72 | MP0002998_abnormal_bone_remodeling | 1.25051618 |
| 73 | MP0005084_abnormal_gallbladder_morpholo | 1.24239687 |
| 74 | MP0008004_abnormal_stomach_pH | 1.23757103 |
| 75 | MP0005167_abnormal_blood-brain_barrier | 1.23150621 |
| 76 | MP0003937_abnormal_limbs/digits/tail_de | 1.21866295 |
| 77 | MP0003755_abnormal_palate_morphology | 1.21702202 |
| 78 | MP0001533_abnormal_skeleton_physiology | 1.21413878 |
| 79 | MP0008789_abnormal_olfactory_epithelium | 1.20824800 |
| 80 | MP0005310_abnormal_salivary_gland | 1.20558992 |
| 81 | MP0005187_abnormal_penis_morphology | 1.20299580 |
| 82 | MP0002184_abnormal_innervation | 1.19931860 |
| 83 | MP0005275_abnormal_skin_tensile | 1.18841289 |
| 84 | MP0002067_abnormal_sensory_capabilities | 1.17237356 |
| 85 | MP0002909_abnormal_adrenal_gland | 1.17230933 |
| 86 | MP0000955_abnormal_spinal_cord | 1.17153490 |
| 87 | MP0004272_abnormal_basement_membrane | 1.16190018 |
| 88 | MP0003300_gastrointestinal_ulcer | 1.14248519 |
| 89 | MP0008569_lethality_at_weaning | 1.12952084 |
| 90 | MP0005166_decreased_susceptibility_to | 1.11374488 |
| 91 | MP0001485_abnormal_pinna_reflex | 1.10308297 |
| 92 | MP0003448_altered_tumor_morphology | 1.07271360 |
| 93 | MP0002736_abnormal_nociception_after | 1.06142069 |
| 94 | MP0000749_muscle_degeneration | 1.06079370 |
| 95 | MP0001879_abnormal_lymphatic_vessel | 1.05061138 |
| 96 | MP0003385_abnormal_body_wall | 1.04086497 |
| 97 | MP0003890_abnormal_embryonic-extraembry | 1.04002735 |
| 98 | MP0000383_abnormal_hair_follicle | 1.03442098 |
| 99 | MP0002882_abnormal_neuron_morphology | 1.02489416 |
| 100 | MP0005464_abnormal_platelet_physiology | 1.01929749 |
| 101 | MP0004742_abnormal_vestibular_system | 1.01811443 |
| 102 | MP0008260_abnormal_autophagy | 1.00410936 |
| 103 | MP0004924_abnormal_behavior | 0.99982035 |
| 104 | MP0005386_behavior/neurological_phenoty | 0.99982035 |
| 105 | MP0000230_abnormal_systemic_arterial | 0.99435058 |
| 106 | MP0004215_abnormal_myocardial_fiber | 0.98570205 |
| 107 | MP0000049_abnormal_middle_ear | 0.98407394 |
| 108 | MP0002896_abnormal_bone_mineralization | 0.98141635 |
| 109 | MP0003631_nervous_system_phenotype | 0.97720726 |
| 110 | MP0005174_abnormal_tail_pigmentation | 0.97607642 |
| 111 | MP0002452_abnormal_antigen_presenting | 0.97559400 |
| 112 | MP0002557_abnormal_social/conspecific_i | 0.97417240 |
| 113 | MP0005623_abnormal_meninges_morphology | 0.96626576 |
| 114 | MP0002066_abnormal_motor_capabilities/c | 0.96064933 |
| 115 | MP0006072_abnormal_retinal_apoptosis | 0.95945384 |
| 116 | MP0005620_abnormal_muscle_contractility | 0.95878515 |
| 117 | MP0004134_abnormal_chest_morphology | 0.95660967 |
| 118 | MP0005253_abnormal_eye_physiology | 0.94888563 |
| 119 | MP0001851_eye_inflammation | 0.93494271 |
| 120 | MP0005195_abnormal_posterior_eye | 0.91666427 |
| 121 | MP0000013_abnormal_adipose_tissue | 0.91219970 |
| 122 | MP0005025_abnormal_response_to | 0.90654739 |
| 123 | MP0003632_abnormal_nervous_system | 0.90234874 |
| 124 | MP0004084_abnormal_cardiac_muscle | 0.89841631 |
| 125 | MP0002233_abnormal_nose_morphology | 0.86496975 |
| 126 | MP0006276_abnormal_autonomic_nervous | 0.84935675 |
| 127 | MP0009697_abnormal_copulation | 0.84896170 |
| 128 | MP0005248_abnormal_Harderian_gland | 0.83437842 |
| 129 | MP0001502_abnormal_circadian_rhythm | 0.81203823 |
| 130 | MP0002723_abnormal_immune_serum | 0.80742601 |
| 131 | MP0002177_abnormal_outer_ear | 0.79644711 |
| 132 | MP0005508_abnormal_skeleton_morphology | 0.79547485 |
| 133 | MP0002229_neurodegeneration | 0.79335314 |
| 134 | MP0009840_abnormal_foam_cell | 0.79306179 |
| 135 | MP0002234_abnormal_pharynx_morphology | 0.78329758 |
| 136 | MP0008775_abnormal_heart_ventricle | 0.77499545 |
| 137 | MP0010352_gastrointestinal_tract_polyps | 0.77412876 |
| 138 | MP0005646_abnormal_pituitary_gland | 0.77277792 |
| 139 | MP0000647_abnormal_sebaceous_gland | 0.76869809 |
| 140 | MP0008877_abnormal_DNA_methylation | 0.76475687 |
| 141 | MP0005394_taste/olfaction_phenotype | 0.75616260 |
| 142 | MP0001177_atelectasis | 0.75551754 |
| 143 | MP0005076_abnormal_cell_differentiation | 0.75167726 |
| 144 | MP0001819_abnormal_immune_cell | 0.72053828 |
| 145 | MP0009785_altered_susceptibility_to | 0.71773461 |
| 146 | MP0004947_skin_inflammation | 0.70741916 |
| 147 | MP0000015_abnormal_ear_pigmentation | 0.70262143 |
| 148 | MP0001958_emphysema | 0.70145279 |
| 149 | MP0003091_abnormal_cell_migration | 0.69971493 |
| 150 | MP0005387_immune_system_phenotype | 0.69630915 |
| 151 | MP0001790_abnormal_immune_system | 0.69630915 |
| 152 | MP0002420_abnormal_adaptive_immunity | 0.67921474 |
| 153 | MP0008438_abnormal_cutaneous_collagen | 0.67824386 |
| 154 | MP0005197_abnormal_uvea_morphology | 0.67374598 |
| 155 | MP0002152_abnormal_brain_morphology | 0.67337585 |
| 156 | MP0008961_abnormal_basal_metabolism | 0.67299040 |
| 157 | MP0004885_abnormal_endolymph | 0.66437665 |
| 158 | MP0003879_abnormal_hair_cell | 0.66254514 |
| 159 | MP0000343_altered_response_to | 0.66053554 |
| 160 | MP0010307_abnormal_tumor_latency | 0.64814361 |
| 161 | MP0001984_abnormal_olfaction | 0.62651680 |
| 162 | MP0005535_abnormal_body_temperature | 0.61902410 |
| 163 | MP0005164_abnormal_response_to | 0.61374331 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased cerebral lipofuscin (HP:0011813) | 5.82898747 |
| 2 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.83481150 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.38391974 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.22553648 |
| 5 | Supranuclear gaze palsy (HP:0000605) | 4.17270700 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.91032751 |
| 7 | Disinhibition (HP:0000734) | 3.87227061 |
| 8 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 3.81801757 |
| 9 | Short 1st metacarpal (HP:0010034) | 3.81801757 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.70477772 |
| 11 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.62893693 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.62893693 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 3.62893693 |
| 14 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.55807500 |
| 15 | Neurofibrillary tangles (HP:0002185) | 3.52695486 |
| 16 | Focal motor seizures (HP:0011153) | 3.52507678 |
| 17 | Mutism (HP:0002300) | 3.45192571 |
| 18 | Abnormality of macrophages (HP:0004311) | 3.43045474 |
| 19 | Increased corneal curvature (HP:0100692) | 3.34496261 |
| 20 | Keratoconus (HP:0000563) | 3.34496261 |
| 21 | Vacuolated lymphocytes (HP:0001922) | 3.31207302 |
| 22 | Dysostosis multiplex (HP:0000943) | 3.27531759 |
| 23 | Abnormality of the 1st metacarpal (HP:0010009) | 3.17893915 |
| 24 | Cerebral inclusion bodies (HP:0100314) | 3.12600959 |
| 25 | Neuronal loss in central nervous system (HP:0002529) | 3.11771151 |
| 26 | Inappropriate behavior (HP:0000719) | 3.09776429 |
| 27 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.07144976 |
| 28 | Focal seizures (HP:0007359) | 3.00509697 |
| 29 | Apathy (HP:0000741) | 2.94697228 |
| 30 | Axonal loss (HP:0003447) | 2.92711973 |
| 31 | Myokymia (HP:0002411) | 2.82127289 |
| 32 | Disproportionate short-trunk short stature (HP:0003521) | 2.79221148 |
| 33 | Type II lissencephaly (HP:0007260) | 2.79103699 |
| 34 | Follicular hyperkeratosis (HP:0007502) | 2.79098136 |
| 35 | Diminished motivation (HP:0000745) | 2.78550461 |
| 36 | Molar tooth sign on MRI (HP:0002419) | 2.76164604 |
| 37 | Abnormality of midbrain morphology (HP:0002418) | 2.76164604 |
| 38 | Visual hallucinations (HP:0002367) | 2.73778205 |
| 39 | Delayed gross motor development (HP:0002194) | 2.71129110 |
| 40 | Ectopic kidney (HP:0000086) | 2.67960590 |
| 41 | Abnormality of binocular vision (HP:0011514) | 2.62993606 |
| 42 | Diplopia (HP:0000651) | 2.62993606 |
| 43 | Mucopolysacchariduria (HP:0008155) | 2.61149319 |
| 44 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.61149319 |
| 45 | J-shaped sella turcica (HP:0002680) | 2.58798256 |
| 46 | Gingivitis (HP:0000230) | 2.51892541 |
| 47 | Akinesia (HP:0002304) | 2.51862359 |
| 48 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.50759245 |
| 49 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.50759245 |
| 50 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.50759245 |
| 51 | Chorioretinal atrophy (HP:0000533) | 2.50036058 |
| 52 | Pancreatic cysts (HP:0001737) | 2.49269950 |
| 53 | Pancreatic fibrosis (HP:0100732) | 2.48247631 |
| 54 | Action tremor (HP:0002345) | 2.44870341 |
| 55 | Loss of speech (HP:0002371) | 2.42991335 |
| 56 | Short phalanx of the thumb (HP:0009660) | 2.42734446 |
| 57 | Fused cervical vertebrae (HP:0002949) | 2.41298085 |
| 58 | Retinal atrophy (HP:0001105) | 2.39542398 |
| 59 | Pendular nystagmus (HP:0012043) | 2.38049692 |
| 60 | Premature rupture of membranes (HP:0001788) | 2.37360117 |
| 61 | Papilledema (HP:0001085) | 2.35013224 |
| 62 | Mediastinal lymphadenopathy (HP:0100721) | 2.34545646 |
| 63 | Nephronophthisis (HP:0000090) | 2.33921325 |
| 64 | Agitation (HP:0000713) | 2.33770287 |
| 65 | Atonic seizures (HP:0010819) | 2.30707231 |
| 66 | Broad ribs (HP:0000885) | 2.30151878 |
| 67 | Lissencephaly (HP:0001339) | 2.29275478 |
| 68 | Small hand (HP:0200055) | 2.28585710 |
| 69 | Hyperventilation (HP:0002883) | 2.24833784 |
| 70 | True hermaphroditism (HP:0010459) | 2.21781753 |
| 71 | Absent frontal sinuses (HP:0002688) | 2.18902490 |
| 72 | Epileptic encephalopathy (HP:0200134) | 2.18493847 |
| 73 | Recurrent skin infections (HP:0001581) | 2.17838831 |
| 74 | Gaze-evoked nystagmus (HP:0000640) | 2.17495236 |
| 75 | Pachygyria (HP:0001302) | 2.17328619 |
| 76 | Chronic obstructive pulmonary disease (HP:0006510) | 2.17179162 |
| 77 | Obstructive lung disease (HP:0006536) | 2.17179162 |
| 78 | Protruding tongue (HP:0010808) | 2.16643185 |
| 79 | Insidious onset (HP:0003587) | 2.16241480 |
| 80 | Termporal pattern (HP:0011008) | 2.16241480 |
| 81 | Absent speech (HP:0001344) | 2.16044713 |
| 82 | Progressive cerebellar ataxia (HP:0002073) | 2.14099441 |
| 83 | Clumsiness (HP:0002312) | 2.13094490 |
| 84 | Dialeptic seizures (HP:0011146) | 2.10815272 |
| 85 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.10658960 |
| 86 | Metaphyseal irregularity (HP:0003025) | 2.09672507 |
| 87 | Stomatitis (HP:0010280) | 2.08508191 |
| 88 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.06361410 |
| 89 | Thyroiditis (HP:0100646) | 2.05734486 |
| 90 | Short hallux (HP:0010109) | 2.05605711 |
| 91 | Absence seizures (HP:0002121) | 2.05183963 |
| 92 | Hypoplasia of the odontoid process (HP:0003311) | 2.01552192 |
| 93 | Generalized tonic-clonic seizures (HP:0002069) | 2.00780558 |
| 94 | Soft skin (HP:0000977) | 2.00487373 |
| 95 | Spastic tetraparesis (HP:0001285) | 2.00113835 |
| 96 | Abnormality of the frontal sinuses (HP:0002687) | 1.98675332 |
| 97 | Tented upper lip vermilion (HP:0010804) | 1.98118259 |
| 98 | Abnormality of the renal medulla (HP:0100957) | 1.96966002 |
| 99 | Abolished electroretinogram (ERG) (HP:0000550) | 1.96718779 |
| 100 | Hip dysplasia (HP:0001385) | 1.96602904 |
| 101 | Neoplasm of the oral cavity (HP:0100649) | 1.96346526 |
| 102 | Hypoplastic iliac wings (HP:0002866) | 1.95115324 |
| 103 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.93082311 |
| 104 | Truncal ataxia (HP:0002078) | 1.91066000 |
| 105 | Arterial tortuosity (HP:0005116) | 1.91062435 |
| 106 | Febrile seizures (HP:0002373) | 1.90936849 |
| 107 | Global brain atrophy (HP:0002283) | 1.90671854 |
| 108 | Progressive inability to walk (HP:0002505) | 1.90393058 |
| 109 | Vitreoretinal degeneration (HP:0000655) | 1.90161072 |
| 110 | Peripheral demyelination (HP:0011096) | 1.89181986 |
| 111 | Abnormality of the odontoid process (HP:0003310) | 1.88906421 |
| 112 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.88591500 |
| 113 | Medial flaring of the eyebrow (HP:0010747) | 1.88115340 |
| 114 | Albinism (HP:0001022) | 1.86675419 |
| 115 | Macroglossia (HP:0000158) | 1.85070325 |
| 116 | Macroorchidism (HP:0000053) | 1.84609675 |
| 117 | Hemiparesis (HP:0001269) | 1.83866703 |
| 118 | Inability to walk (HP:0002540) | 1.83630334 |
| 119 | Irregular vertebral endplates (HP:0003301) | 1.83248817 |
| 120 | Increased CSF protein (HP:0002922) | 1.82818007 |
| 121 | Choroideremia (HP:0001139) | 1.82435749 |
| 122 | Chronic hepatic failure (HP:0100626) | 1.82434626 |
| 123 | Aortic dissection (HP:0002647) | 1.82259553 |
| 124 | Polyphagia (HP:0002591) | 1.81141649 |
| 125 | Carpal bone hypoplasia (HP:0001498) | 1.80575471 |
| 126 | Congenital sensorineural hearing impairment (HP:0008527) | 1.80234166 |
| 127 | Barrel-shaped chest (HP:0001552) | 1.79380392 |
| 128 | Depression (HP:0000716) | 1.78848731 |
| 129 | Abnormal eating behavior (HP:0100738) | 1.78747195 |
| 130 | Slow saccadic eye movements (HP:0000514) | 1.78513438 |
| 131 | Esotropia (HP:0000565) | 1.78447336 |
| 132 | Rapidly progressive (HP:0003678) | 1.78422926 |
| 133 | Adactyly (HP:0009776) | 1.77996053 |
| 134 | Lower limb amyotrophy (HP:0007210) | 1.76723267 |
| 135 | Broad-based gait (HP:0002136) | 1.76519197 |
| 136 | Agnosia (HP:0010524) | 1.76340896 |
| 137 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.75610148 |
| 138 | Widely spaced teeth (HP:0000687) | 1.74158017 |
| 139 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.73434817 |
| 140 | Thick nail (HP:0001805) | 1.72373400 |
| 141 | Drooling (HP:0002307) | 1.71809543 |
| 142 | Excessive salivation (HP:0003781) | 1.71809543 |
| 143 | Abnormality of the parathyroid morphology (HP:0011766) | 1.71799455 |
| 144 | Dementia (HP:0000726) | 1.71758575 |
| 145 | Severe muscular hypotonia (HP:0006829) | 1.71612823 |
| 146 | Retinal dysplasia (HP:0007973) | 1.71069831 |
| 147 | Abnormality of the corticospinal tract (HP:0002492) | 1.71024970 |
| 148 | Erythroderma (HP:0001019) | 1.69222710 |
| 149 | Hematochezia (HP:0002573) | 1.69128655 |
| 150 | Cerebellar dysplasia (HP:0007033) | 1.68723451 |
| 151 | Genetic anticipation (HP:0003743) | 1.67950808 |
| 152 | Stenosis of the external auditory canal (HP:0000402) | 1.67096153 |
| 153 | Mesomelia (HP:0003027) | 1.66819805 |
| 154 | Vascular tortuosity (HP:0004948) | 1.65930965 |
| 155 | Decreased muscle mass (HP:0003199) | 1.65816511 |
| 156 | Stereotypic behavior (HP:0000733) | 1.65494162 |
| 157 | Ankle clonus (HP:0011448) | 1.64768142 |
| 158 | Prostate neoplasm (HP:0100787) | 1.63868116 |
| 159 | Optic nerve hypoplasia (HP:0000609) | 1.63842224 |
| 160 | Atrophic scars (HP:0001075) | 1.63504624 |
| 161 | Spondylolisthesis (HP:0003302) | 1.63410289 |
| 162 | Abnormality of the carotid arteries (HP:0005344) | 1.60787801 |
| 163 | Dysmetria (HP:0001310) | 1.60636022 |
| 164 | Retrobulbar optic neuritis (HP:0100654) | 1.60607616 |
| 165 | Optic neuritis (HP:0100653) | 1.60607616 |
| 166 | Postural instability (HP:0002172) | 1.60281920 |
| 167 | Bladder diverticulum (HP:0000015) | 1.60203503 |
| 168 | Upper motor neuron abnormality (HP:0002127) | 1.60149804 |
| 169 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.59835711 |
| 170 | Thoracolumbar scoliosis (HP:0002944) | 1.59611020 |
| 171 | Dandy-Walker malformation (HP:0001305) | 1.59475610 |
| 172 | Lower limb muscle weakness (HP:0007340) | 1.58325159 |
| 173 | Lower limb asymmetry (HP:0100559) | 1.58110201 |
| 174 | Intention tremor (HP:0002080) | 1.57754378 |
| 175 | Abnormality of the periventricular white matter (HP:0002518) | 1.57704748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.11377102 |
| 2 | ADRBK2 | 3.24426317 |
| 3 | FRK | 3.20436164 |
| 4 | MAP3K9 | 2.83551385 |
| 5 | MARK1 | 2.63732573 |
| 6 | CASK | 2.59548166 |
| 7 | NTRK3 | 2.53826957 |
| 8 | TNIK | 2.48719512 |
| 9 | EPHA4 | 2.48524737 |
| 10 | TRIM28 | 2.41821087 |
| 11 | DAPK2 | 2.27413853 |
| 12 | GRK7 | 2.20020938 |
| 13 | KSR2 | 2.19805190 |
| 14 | PAK6 | 2.16960533 |
| 15 | MAP4K2 | 2.09375468 |
| 16 | NTRK1 | 1.96835863 |
| 17 | BMPR1B | 1.95768805 |
| 18 | MAPK13 | 1.93072961 |
| 19 | GRK1 | 1.91505740 |
| 20 | SIK2 | 1.90519294 |
| 21 | FES | 1.87940307 |
| 22 | MINK1 | 1.87807290 |
| 23 | EPHB2 | 1.78718927 |
| 24 | FGR | 1.71087799 |
| 25 | WNK3 | 1.71010553 |
| 26 | CAMKK1 | 1.64547496 |
| 27 | MAP3K13 | 1.62384007 |
| 28 | NTRK2 | 1.61220580 |
| 29 | BMX | 1.56701467 |
| 30 | PBK | 1.56591325 |
| 31 | PINK1 | 1.55939874 |
| 32 | MAP3K4 | 1.40929581 |
| 33 | ARAF | 1.37616038 |
| 34 | CDK5 | 1.37284784 |
| 35 | ACVR1B | 1.37192015 |
| 36 | KSR1 | 1.35909682 |
| 37 | TBK1 | 1.30723702 |
| 38 | STK3 | 1.30532047 |
| 39 | MKNK2 | 1.28166444 |
| 40 | PLK2 | 1.26862041 |
| 41 | DYRK3 | 1.24986288 |
| 42 | PNCK | 1.23660056 |
| 43 | LIMK1 | 1.23121544 |
| 44 | TGFBR2 | 1.21310322 |
| 45 | RET | 1.21128297 |
| 46 | EPHB1 | 1.19202567 |
| 47 | BRSK2 | 1.18731978 |
| 48 | PRKCH | 1.17664326 |
| 49 | MYLK | 1.16480221 |
| 50 | CSNK1G3 | 1.15230372 |
| 51 | SCYL2 | 1.13226537 |
| 52 | MAP3K2 | 1.12157713 |
| 53 | CSNK1G1 | 1.10623954 |
| 54 | TRIB3 | 1.09956066 |
| 55 | LATS2 | 1.09869792 |
| 56 | CAMK1G | 1.09363434 |
| 57 | KIT | 1.08979570 |
| 58 | STK38L | 1.06822021 |
| 59 | CAMKK2 | 1.05943591 |
| 60 | NUAK1 | 1.05427918 |
| 61 | AKT3 | 1.04280219 |
| 62 | BLK | 1.04108142 |
| 63 | MAP3K14 | 1.02943681 |
| 64 | ERBB3 | 1.00778258 |
| 65 | NEK1 | 0.96755673 |
| 66 | PIM2 | 0.95298803 |
| 67 | FLT3 | 0.94544491 |
| 68 | HCK | 0.92450484 |
| 69 | ICK | 0.92391766 |
| 70 | ZAK | 0.92381188 |
| 71 | TYRO3 | 0.90297361 |
| 72 | NEK9 | 0.89876403 |
| 73 | PDGFRB | 0.89038538 |
| 74 | PRKD3 | 0.87710558 |
| 75 | FYN | 0.87659628 |
| 76 | RIPK1 | 0.87457665 |
| 77 | FGFR2 | 0.87273605 |
| 78 | IRAK2 | 0.86482896 |
| 79 | CCNB1 | 0.86118577 |
| 80 | UHMK1 | 0.82432168 |
| 81 | DDR2 | 0.82341286 |
| 82 | IRAK3 | 0.81872137 |
| 83 | MKNK1 | 0.81323998 |
| 84 | EIF2AK3 | 0.81002973 |
| 85 | MAP2K7 | 0.80785170 |
| 86 | CSNK1G2 | 0.79012413 |
| 87 | SIK3 | 0.78963215 |
| 88 | TGFBR1 | 0.78766344 |
| 89 | CDK14 | 0.78075589 |
| 90 | LATS1 | 0.77914317 |
| 91 | PDPK1 | 0.76529798 |
| 92 | JAK1 | 0.76275006 |
| 93 | IRAK4 | 0.76005969 |
| 94 | GRK5 | 0.75607472 |
| 95 | PLK3 | 0.75322334 |
| 96 | ALK | 0.75235534 |
| 97 | MOS | 0.74808297 |
| 98 | MUSK | 0.74329002 |
| 99 | PDGFRA | 0.73087967 |
| 100 | BMPR2 | 0.71778279 |
| 101 | ADRBK1 | 0.70664004 |
| 102 | SYK | 0.69723437 |
| 103 | CDK18 | 0.69224524 |
| 104 | PDK1 | 0.68588407 |
| 105 | DAPK1 | 0.68464616 |
| 106 | ABL2 | 0.68175335 |
| 107 | PRPF4B | 0.68041412 |
| 108 | PTK2B | 0.67943850 |
| 109 | CDK15 | 0.67791138 |
| 110 | DYRK2 | 0.67698984 |
| 111 | MAP3K1 | 0.67265726 |
| 112 | EGFR | 0.66327989 |
| 113 | PRKCE | 0.66151748 |
| 114 | CAMK1D | 0.65400097 |
| 115 | PTK6 | 0.62491385 |
| 116 | CAMK2D | 0.60886087 |
| 117 | MATK | 0.60847476 |
| 118 | PRKCG | 0.59386241 |
| 119 | ROCK1 | 0.59154884 |
| 120 | CAMK2A | 0.58878180 |
| 121 | BCR | 0.58535344 |
| 122 | JAK2 | 0.58383411 |
| 123 | WNK1 | 0.57816056 |
| 124 | RPS6KA2 | 0.57784586 |
| 125 | SGK1 | 0.56023699 |
| 126 | ERBB4 | 0.55915802 |
| 127 | TTN | 0.55515609 |
| 128 | PAK3 | 0.54848531 |
| 129 | CLK1 | 0.54143146 |
| 130 | PHKG1 | 0.53965894 |
| 131 | PHKG2 | 0.53965894 |
| 132 | WEE1 | 0.53816596 |
| 133 | CDK11A | 0.53758146 |
| 134 | MAP2K4 | 0.52437371 |
| 135 | PAK2 | 0.52063039 |
| 136 | DMPK | 0.51953248 |
| 137 | INSRR | 0.51467853 |
| 138 | SRC | 0.50861531 |
| 139 | HIPK2 | 0.50120270 |
| 140 | CAMK2B | 0.49630618 |
| 141 | PRKCZ | 0.49221004 |
| 142 | MAP3K12 | 0.48724708 |
| 143 | TAOK1 | 0.48202789 |
| 144 | PLK4 | 0.48066110 |
| 145 | TAF1 | 0.47881617 |
| 146 | CSNK1A1L | 0.47640865 |
| 147 | CHUK | 0.46389359 |
| 148 | EPHA3 | 0.45388788 |
| 149 | GSK3A | 0.44016446 |
| 150 | STK39 | 0.42309277 |
| 151 | ABL1 | 0.42213990 |
| 152 | PRKCD | 0.41988048 |
| 153 | MAP2K1 | 0.41933367 |
| 154 | CSF1R | 0.41546980 |
| 155 | CDC42BPA | 0.41390279 |
| 156 | MAPK10 | 0.40730315 |
| 157 | MARK2 | 0.40707111 |
| 158 | PKN1 | 0.40443526 |
| 159 | MARK3 | 0.38795687 |
| 160 | CSNK1D | 0.37174657 |
| 161 | IKBKB | 0.36782037 |
| 162 | CAMK2G | 0.36226063 |
| 163 | TAOK3 | 0.35011647 |
| 164 | CSNK1A1 | 0.33832520 |
| 165 | MET | 0.33633883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.56872785 |
| 2 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.25268075 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 2.08988758 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.98127433 |
| 5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.82149220 |
| 6 | Phagosome_Homo sapiens_hsa04145 | 1.80792043 |
| 7 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.73183941 |
| 8 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.70241797 |
| 9 | Phototransduction_Homo sapiens_hsa04744 | 1.69606305 |
| 10 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.63176706 |
| 11 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.62462431 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.59844063 |
| 13 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.57786479 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 1.57704052 |
| 15 | Nicotine addiction_Homo sapiens_hsa05033 | 1.56215669 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.55843863 |
| 17 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.55148481 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.51251772 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.49309515 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 1.46230839 |
| 21 | Protein export_Homo sapiens_hsa03060 | 1.45583155 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.45402584 |
| 23 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.44606755 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.44509506 |
| 25 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.42042491 |
| 26 | Circadian entrainment_Homo sapiens_hsa04713 | 1.38167586 |
| 27 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.36419717 |
| 28 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.36386482 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.34862069 |
| 30 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.34527159 |
| 31 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.33573016 |
| 32 | Olfactory transduction_Homo sapiens_hsa04740 | 1.33566940 |
| 33 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.32269288 |
| 34 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.28141368 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.26716392 |
| 36 | Long-term potentiation_Homo sapiens_hsa04720 | 1.26595845 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.25947149 |
| 38 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.24186899 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24118700 |
| 40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.21717597 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.20442368 |
| 42 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.19916125 |
| 43 | Melanoma_Homo sapiens_hsa05218 | 1.17900362 |
| 44 | Basal transcription factors_Homo sapiens_hsa03022 | 1.17856653 |
| 45 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.13863193 |
| 46 | Insulin secretion_Homo sapiens_hsa04911 | 1.11736222 |
| 47 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08907822 |
| 48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.08563483 |
| 49 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.07772537 |
| 50 | Cocaine addiction_Homo sapiens_hsa05030 | 1.06709861 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06191094 |
| 52 | Salivary secretion_Homo sapiens_hsa04970 | 1.06184767 |
| 53 | Long-term depression_Homo sapiens_hsa04730 | 1.05359199 |
| 54 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.03112276 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02963579 |
| 56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.01958902 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 1.01637056 |
| 58 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.01506494 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 1.00563926 |
| 60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.00092306 |
| 61 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.99990351 |
| 62 | Glioma_Homo sapiens_hsa05214 | 0.99290133 |
| 63 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.98289930 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.98125004 |
| 65 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97668673 |
| 66 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.97590150 |
| 67 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.97557723 |
| 68 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.97210289 |
| 69 | Malaria_Homo sapiens_hsa05144 | 0.97110787 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.94608593 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.93086148 |
| 72 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.92392474 |
| 73 | Axon guidance_Homo sapiens_hsa04360 | 0.91886728 |
| 74 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.91398897 |
| 75 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.90974278 |
| 76 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.90720345 |
| 77 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.90326052 |
| 78 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90051442 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.89876974 |
| 80 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.89546777 |
| 81 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.89199566 |
| 82 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88691312 |
| 83 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.88519889 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87642126 |
| 85 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.84480837 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.84479914 |
| 87 | Gap junction_Homo sapiens_hsa04540 | 0.84381591 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83837840 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83320975 |
| 90 | Focal adhesion_Homo sapiens_hsa04510 | 0.82896865 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.82408042 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.82248424 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81527606 |
| 94 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.80528756 |
| 95 | Shigellosis_Homo sapiens_hsa05131 | 0.79118018 |
| 96 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.77713517 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.77588025 |
| 98 | Legionellosis_Homo sapiens_hsa05134 | 0.74573626 |
| 99 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.73346373 |
| 100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72719881 |
| 101 | Circadian rhythm_Homo sapiens_hsa04710 | 0.72373929 |
| 102 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.71633185 |
| 103 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.70144329 |
| 104 | Asthma_Homo sapiens_hsa05310 | 0.67712171 |
| 105 | Platelet activation_Homo sapiens_hsa04611 | 0.67329180 |
| 106 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66561110 |
| 107 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.66099826 |
| 108 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.66094834 |
| 109 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65794937 |
| 110 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65379246 |
| 111 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.65078896 |
| 112 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64919373 |
| 113 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.64833046 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | 0.64791258 |
| 115 | Taste transduction_Homo sapiens_hsa04742 | 0.63807569 |
| 116 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.63253232 |
| 117 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63112733 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62877889 |
| 119 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.62518142 |
| 120 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60955781 |
| 121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60792411 |
| 122 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60736232 |
| 123 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60344744 |
| 124 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.60081947 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59606434 |
| 126 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.59142204 |
| 127 | Other glycan degradation_Homo sapiens_hsa00511 | 0.59016887 |
| 128 | Prion diseases_Homo sapiens_hsa05020 | 0.58725127 |
| 129 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57928271 |
| 130 | Pathways in cancer_Homo sapiens_hsa05200 | 0.57486015 |
| 131 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.56968826 |
| 132 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.56078382 |
| 133 | Melanogenesis_Homo sapiens_hsa04916 | 0.55735736 |
| 134 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55414421 |
| 135 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55235274 |
| 136 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.54465875 |
| 137 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.54297478 |
| 138 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.53253147 |
| 139 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.52867241 |
| 140 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.51906646 |
| 141 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50660849 |
| 142 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47530261 |
| 143 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.45957080 |
| 144 | Mineral absorption_Homo sapiens_hsa04978 | 0.45241027 |
| 145 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.44837380 |
| 146 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.44549874 |

